Steris (STE) Tops Q1 EPS by 25c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
STERIS (STE) PT Raised to $254 at Needham & Company
August 10, 2021 12:05 PM EDTNeedham & Company analyst Mike Matson raised the price target on STERIS (NYSE: STE) to $254.00 (from $233.00) while maintaining a Buy rating.
The analyst commented, "STE's F1Q22 revenue and EPS beat consensus. Organic revenue growth improved significantly from the prior quarter as STE lapped the... More



